TheStreet lowered shares of SurModics Inc. (NASDAQ:SRDX) from a buy rating to a hold rating in a research note released on Monday.

Other analysts also recently issued research reports about the company. Zacks Investment Research upgraded SurModics from a hold rating to a buy rating and set a $32.00 price target on the stock in a research note on Thursday, October 20th. Barrington Research cut SurModics from an outperform rating to a market perform rating in a report on Monday, November 21st. Finally, Sidoti cut SurModics from a buy rating to a neutral rating and set a $33.00 price objective for the company. in a report on Thursday, October 6th.

SurModics (NASDAQ:SRDX) opened at 23.95 on Monday. The stock has a market cap of $313.46 million, a PE ratio of 31.51 and a beta of 0.98. SurModics has a 12-month low of $17.45 and a 12-month high of $30.75. The firm’s 50-day moving average price is $26.64 and its 200 day moving average price is $26.23.

SurModics (NASDAQ:SRDX) last posted its quarterly earnings results on Wednesday, November 16th. The company reported $0.26 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.09 by $0.17. The business had revenue of $18.20 million for the quarter, compared to the consensus estimate of $16.09 million. SurModics had a return on equity of 15.98% and a net margin of 13.99%. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.30 EPS. Analysts anticipate that SurModics will post $1.04 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “TheStreet Lowers SurModics Inc. (SRDX) to Hold” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another site, it was stolen and republished in violation of United States & international copyright legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2016/12/01/thestreet-lowers-surmodics-inc-srdx-to-hold.html.

In related news, CEO Gary R. Maharaj sold 5,000 shares of the company’s stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $25.22, for a total value of $126,100.00. Following the completion of the transaction, the chief executive officer now owns 130,207 shares of the company’s stock, valued at approximately $3,283,820.54. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 7.20% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in the company. Prudential Financial Inc. boosted its position in SurModics by 1.0% in the second quarter. Prudential Financial Inc. now owns 46,622 shares of the company’s stock worth $1,095,000 after buying an additional 460 shares during the last quarter. Bank of Montreal Can acquired a new position in SurModics during the second quarter worth $190,000. Gabelli Funds LLC boosted its position in SurModics by 2.4% in the second quarter. Gabelli Funds LLC now owns 128,626 shares of the company’s stock worth $3,020,000 after buying an additional 3,000 shares during the last quarter. Emerald Acquisition Ltd. acquired a new position in SurModics during the second quarter worth $4,581,000. Finally, Ameriprise Financial Inc. boosted its position in SurModics by 6.7% in the second quarter. Ameriprise Financial Inc. now owns 65,348 shares of the company’s stock worth $1,535,000 after buying an additional 4,132 shares during the last quarter. 88.55% of the stock is owned by institutional investors.

About SurModics

SurModics, Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company is focused on to transform its medical device business from being a provider of coating technologies to offering whole product solutions to medical device customers.

5 Day Chart for NASDAQ:SRDX

Receive News & Stock Ratings for SurModics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurModics Inc. and related stocks with our FREE daily email newsletter.